IMTX Новости Форекс
Moderna, Immatics Ink Strategic Multi-Platform Collaboration To Develop Oncology Therapeutics
Biopharmaceutical company Moderna, Inc. (MRNA) and Germany-based Immatics N.V. (IMTX) announced Monday a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need.
RTTNews
|
405 дней спустя
